Search results
Showing results for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
©
John Cairns
Work with us
Work with us
EPIONE
The EPIONE study
What will you learn?
What will you learn?
AI in the workplace
AI in the workplace
Student and alumni spotlights
Student and alumni spotlights
Postgraduate Certificate in Patient Safety and Quality Improvement
Postgraduate Certificate (PGCert) in Patient Safety and Quality Improvement
Student and alumni spotlights
Student and alumni spotlights
Why was the course developed?
Why the MSc in Surgical Science and Practice?
What will you learn?
Who will you learn from?
Collaborations
Oxford University Global Surgery Group collaborations
Support us
Support the Oxford University Global Surgery Group
News and events
OUGSG news and events